看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 32.8x - 36.3x | 34.6x |
| Selected Fwd EBIT Multiple | 36.3x - 40.1x | 38.2x |
| Fair Value | ﷼18.10 - ﷼20.02 | ﷼19.06 |
| Upside | -19.9% - -11.4% | -15.7% |
| Benchmarks | Ticker | Full Ticker |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Al-Modawat Specialized Medical Company | 9594 | SASE:9594 |
| Canadian General Medical Center Complex Company | 9518 | SASE:9518 |
| Alf Meem Yaa for Medical Supplies and Equipment Company | 9527 | SASE:9527 |
| Twareat Medical Care Company | 9627 | SASE:9627 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 4007 | 4013 | 9594 | 9518 | 9527 | 9627 | ||
| SASE:4007 | SASE:4013 | SASE:9594 | SASE:9518 | SASE:9527 | SASE:9627 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 16.3% | 22.1% | NM- | NM- | 24.8% | NM- | |
| 3Y CAGR | 31.9% | 17.1% | NM- | -2.9% | 26.4% | NM- | |
| Latest Twelve Months | -10.7% | 12.4% | -27.9% | -31.6% | 33.9% | NM | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 21.3% | 20.3% | 21.7% | 20.3% | 17.4% | 12.9% | |
| Prior Fiscal Year | 29.1% | 22.0% | 20.7% | 21.0% | 16.7% | 18.0% | |
| Latest Fiscal Year | 26.5% | 21.0% | 29.4% | 15.5% | 19.9% | 9.0% | |
| Latest Twelve Months | 26.5% | 21.0% | 19.0% | 10.5% | 19.9% | 13.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.52x | 9.38x | 5.56x | 4.20x | 3.40x | 5.26x | |
| EV / LTM EBITDA | 16.3x | 38.8x | 25.7x | 36.5x | 16.9x | 35.6x | |
| EV / LTM EBIT | 20.8x | 44.6x | 29.2x | 40.1x | 17.1x | 39.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 17.1x | 29.2x | 44.6x | ||||
| Historical EV / LTM EBIT | 0.0x | NM | 0.0x | ||||
| Selected EV / LTM EBIT | 32.8x | 34.6x | 36.3x | ||||
| (x) LTM EBIT | 23 | 23 | 23 | ||||
| (=) Implied Enterprise Value | 761 | 801 | 842 | ||||
| (-) Non-shareholder Claims * | (7) | (7) | (7) | ||||
| (=) Equity Value | 755 | 795 | 835 | ||||
| (/) Shares Outstanding | 40.0 | 40.0 | 40.0 | ||||
| Implied Value Range | 18.87 | 19.87 | 20.87 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 18.87 | 19.87 | 20.87 | 22.60 | |||
| Upside / (Downside) | -16.5% | -12.1% | -7.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4007 | 4013 | 9594 | 9518 | 9527 | 9627 | |
| Enterprise Value | 6,340 | 104,647 | 412 | 446 | 815 | 911 | |
| (+) Cash & Short Term Investments | 245 | 2,891 | 25 | 45 | 24 | 3 | |
| (+) Investments & Other | 135 | 465 | 0 | 0 | 0 | 0 | |
| (-) Debt | (304) | (8,165) | (13) | (8) | (2) | (9) | |
| (-) Other Liabilities | 0 | (438) | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 6,416 | 99,400 | 424 | 484 | 837 | 904 | |
| (/) Shares Outstanding | 160.0 | 350.0 | 23.8 | 77.0 | 7.0 | 40.0 | |
| Implied Stock Price | 40.10 | 284.00 | 17.84 | 6.29 | 119.60 | 22.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 40.10 | 284.00 | 17.84 | 6.29 | 119.60 | 22.60 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |